The Cure Hidden in an Old Book

The story

In 1967, during the Vietnam War, the North Vietnamese government asked China for help with a problem that was killing soldiers: malaria. The parasite had become resistant to chloroquine, then the standard treatment. Something new was needed.

China launched a secret research programme known as Project 523. In 1969, the task of leading one of its research groups was given to Tu Youyou, a pharmaceutical chemist in her late thirties at the Academy of Traditional Chinese Medicine in Beijing.

Tu and her colleagues began with the obvious resource: the long Chinese tradition of herbal medicine. They screened hundreds of plants and recipes. Progress was slow. Many extracts killed the parasite in the laboratory but were too toxic, or failed in animals.

Then Tu went back to the texts.

The question that started it all

Can an ancient recipe become a modern medicine?

The question was not sentimental. Tu was not looking for wisdom in the abstract. She was looking for a molecule.

One text, written by Ge Hong in the fourth century, described a treatment for intermittent fevers: take a handful of qinghao — sweet wormwood, Artemisia annua — soak it in water, wring out the juice and drink it. The instruction was unusual. Most herbal preparations were boiled. This one seemed to emphasise cold extraction.

Tu wondered whether heat was destroying the active compound. Her team switched to a low-temperature ether extraction. In 1971, an extract labelled number 191 produced complete inhibition of the malaria parasite in laboratory animals.

The journey

The result was not the end. The team still had to isolate the active substance, establish its safety and test it in people.

In 1972, they isolated colourless crystals that would become known as artemisinin. Before giving the new drug to patients, Tu and several colleagues took it themselves to check for acute toxicity. Clinical trials followed.

The work was published collectively in 1977, during the Cultural Revolution, without individual authorship. For years, the discovery was known mainly within China. International recognition came much later.

In 2015, Tu received the Nobel Prize in Physiology or Medicine, shared with William C. Campbell and Satoshi Ōmura for their work on other parasitic diseases. She was the first Chinese scientist to receive a Nobel Prize in Physiology or Medicine. She was eighty-four.

What this tells us about humanity

The story is often told as a triumph of ancient wisdom. That version is too simple, and it undersells what actually happened.

The old text pointed toward a plant. It did not provide a dose, a molecule, a safety profile or a clinical trial. Those came from modern chemistry, animal studies, careful measurement and a large, state-organised research effort. Tu’s contribution was to read an old instruction with a modern question in mind: why cold, and not hot?

That is a particular human move — taking the accumulated knowledge of the dead and asking it a new question. It is also a collective move. The Nobel citation names Tu, but the work depended on many unnamed researchers, clinicians and patients.

Why it matters

Artemisinin-based combination therapies became the frontline treatment for malaria and have saved millions of lives. The World Health Organization estimates that malaria still causes hundreds of thousands of deaths each year, most of them children in Africa. The drug is not a final victory, and resistance to artemisinin is a serious concern. But it changed the odds.

The story also matters because it complicates the way we talk about progress. The cure was not invented from nothing, and it was not simply inherited from the past. It was made at the intersection of a fourth-century text, twentieth-century chemistry, a wartime emergency and a group of people willing to test their own product.